STACI AMBROSE: Open Payments
NPI 1851970610 · LUTHERVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 69 payments from 16 companies in 2025. Trend: 2023 $976 · 2024 $1,364 · 2025 $1,499
Food & beverage: $1,499
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $339 |
| Novartis Pharmaceuticals Corporation | 14 | $282 |
| ABBVIE INC. | 13 | $192 |
| Regeneron Healthcare Solutions, Inc. | 7 | $158 |
| UCB, Inc. | 4 | $98 |
| Galderma Laboratories, L.P. | 5 | $86 |
| PFIZER INC. | 4 | $69 |
| Organon LLC | 3 | $49 |
| Lilly USA, LLC | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
Products named: DUPIXENT, COSENTYX, SKYRIZI, Bimzelx, RINVOQ, Rhapsido, CIBINQO, NEMLUVIO.
Industry payments across MD — which companies pay providers there.
